Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30449623

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2019 Jan 5
First author
Mehanna H

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Jan 5;393(10166):5-7. doi: 10.1016/S0140-6736(18)32930-1.
    note
    Source null
    related pmid
    30449624
    relationship
    Comment in
  2. citation
    Strahlenther Onkol. 2019 May;195(5):447-449. doi: 10.1007/s00066-019-01441-w.
    note
    Source null
    related pmid
    30789992
    relationship
    Comment in
  3. citation
    Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):705-709. doi: 10.1016/j.ijrobp.2019.02.054.
    note
    Source null
    related pmid
    31204653
    relationship
    Comment in
  4. citation
    Bull Cancer. 2020 Mar;107(3):293-294. doi: 10.1016/j.bulcan.2020.02.002.
    note
    Source null
    related pmid
    32113612
    relationship
    Comment in

Authors and identifiers

  1. name
    Mehanna H
    type
    Author
  2. name
    Robinson M
    type
    Author
  3. name
    Hartley A
    type
    Author
  4. name
    Kong A
    type
    Author
  5. name
    Foran B
    type
    Author
  6. name
    Fulton-Lieuw T
    type
    Author
  7. name
    Dalby M
    type
    Author
  8. name
    Mistry P
    type
    Author
  9. name
    Sen M
    type
    Author
  10. name
    O'Toole L
    type
    Author
  11. name
    Al Booz H
    type
    Author
  12. name
    Dyker K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mehanna H
    type
    Author
  2. name
    Robinson M
    type
    Author
  3. name
    Hartley A
    type
    Author
  4. name
    Kong A
    type
    Author
  5. name
    Foran B
    type
    Author
  6. name
    Fulton-Lieuw T
    type
    Author
  7. name
    Dalby M
    type
    Author
  8. name
    Mistry P
    type
    Author
  9. name
    Sen M
    type
    Author
  10. name
    O'Toole L
    type
    Author
  11. name
    Al Booz H
    type
    Author
  12. name
    Dyker K
    type
    Author
bibliography ids
  1. nci-bib-772e59cd17df3f7b98451c0e
book metadata
content sha256
f12c58a2c932cf41aedffeea660c958afc253075ddfaf70837d34061a581868e
document type
citation
dois
  1. 10.1016/S0140-6736(18)32752-1
electronic publication date
display
2018 Nov 15
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30449623
immutable id
pubmed:30449623@f12c58a2c932cf41aedffeea660c958afc253075ddfaf70837d34061a581868e
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10166
name
Lancet (London, England)
nlm unique id
2985213R
pages
51-60
volume
393
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2019 Jan 5;393(10166):5-7. doi: 10.1016/S0140-6736(18)32930-1.
    note
    Source null
    related pmid
    30449624
    relationship
    Comment in
  2. citation
    Strahlenther Onkol. 2019 May;195(5):447-449. doi: 10.1007/s00066-019-01441-w.
    note
    Source null
    related pmid
    30789992
    relationship
    Comment in
  3. citation
    Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):705-709. doi: 10.1016/j.ijrobp.2019.02.054.
    note
    Source null
    related pmid
    31204653
    relationship
    Comment in
  4. citation
    Bull Cancer. 2020 Mar;107(3):293-294. doi: 10.1016/j.bulcan.2020.02.002.
    note
    Source null
    related pmid
    32113612
    relationship
    Comment in
outcomes validated
false
pmid
30449623
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
1900a2be197acfaa741d27d9d11624462b1c86e1272ecb05c8561624c9bd14e0
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2019 Jan 5
precision
day
year
2019
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30449623/
title
Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.

Preserved source evidence · Not medical advice